← Back to Analyst Consensus 
OCGN Buy
Ocugen, Inc.
Current Price —
Implied Upside —
Analysts 12
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 10, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 27, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Mar 25, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Mar 25, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 17, 2026 | Canaccord Genuity | initiate | — → Buy | — | 48% |
| Mar 11, 2026 | Oppenheimer | initiate | — → Outperform | — | 52% |
| Mar 5, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Jan 20, 2026 | Chardan Capital | maintain | Buy → Buy | $7 | 47% |
| Sep 19, 2025 | Chardan Capital | maintain | Buy → Buy | $7 | 47% |
| Aug 4, 2025 | Chardan Capital | maintain | Buy → Buy | $7 | 47% |
| Jun 24, 2025 | Chardan Capital | maintain | Buy → Buy | $7 | 47% |
| Jun 24, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| May 12, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| May 12, 2025 | Chardan Capital | maintain | Buy → Buy | $7 | 47% |
| Mar 6, 2025 | Chardan Capital | maintain | Buy → Buy | $7 | 47% |
| Mar 6, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Feb 13, 2025 | Chardan Capital | maintain | Buy → Buy | $6 | 47% |
| Feb 13, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $8 | 44% |
| Jan 23, 2025 | Chardan Capital | maintain | Buy → Buy | $6 | 47% |
| Jan 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Nov 18, 2024 | Chardan Capital | maintain | Buy → Buy | $6 | 47% |
| Nov 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Nov 11, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Nov 8, 2024 | Chardan Capital | maintain | Buy → Buy | $6 | 47% |
| Oct 23, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Oct 15, 2024 | Maxim Group | initiate | — → Buy | $4 | 42% |
| May 15, 2024 | Chardan Capital | maintain | Buy → Buy | $5 | 47% |
| May 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Apr 22, 2024 | Chardan Capital | maintain | Buy → Buy | $5 | 47% |
| Apr 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Feb 22, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Jan 24, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Aug 31, 2023 | Cantor Fitzgerald | maintain | Overweight → Overweight | $2 | 50% |
| Aug 23, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| May 8, 2023 | Chardan Capital | maintain | — → Buy | $4 | 47% |
| Apr 17, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $5 | 44% |
| Apr 14, 2023 | Chardan Capital | maintain | — → Buy | $3.5 | 47% |
| Mar 1, 2023 | Chardan Capital | upgrade | Neutral → Buy | $3.5 | 47% |
| Mar 1, 2023 | Mizuho | maintain | — → Buy | $3 | 52% |
| Mar 1, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $5 | 44% |
| Aug 23, 2022 | Mizuho | initiate | — → Buy | $5 | 52% |
| Aug 15, 2022 | HC Wainwright & Co. | maintain | — → Buy | $6 | 44% |
| Jun 2, 2022 | Cantor Fitzgerald | initiate | — → Overweight | $4.5 | 50% |
| May 12, 2022 | HC Wainwright & Co. | maintain | — → Buy | $7 | 44% |
| Feb 28, 2022 | HC Wainwright & Co. | maintain | — → Buy | $8 | 44% |
| Jun 11, 2021 | Roth Capital | downgrade | Buy → Neutral | $6 | 53% |
| Jun 11, 2021 | HC Wainwright & Co. | maintain | — → Buy | $10 | 44% |
| May 7, 2021 | Cantor Fitzgerald | downgrade | Overweight → Neutral | $11 | 50% |
| Mar 3, 2021 | Cantor Fitzgerald | maintain | — → Overweight | $15 | 50% |
| Feb 9, 2021 | Chardan Capital | downgrade | Buy → Neutral | $13 | 47% |
Price Target Trend
Apr 26, 2026 Oct 26, 2026
EPS Estimates
0y —
+1y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days